Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 1:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1945–1968 of 21,991 matching trials from the live ClinicalTrials.gov search.

Filters: Recruiting Clear all

Conditions: Mania, Bipolar Disorder
Interventions: Xanomeline/Trospium Chloride, Placebo; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 424 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 22
States / cities: Bentonville, Arkansas • Little Rock, Arkansas • Bellflower, California + 19 more

Conditions: Gastroparesis, Functional Dyspepsia
Interventions: Gastric Alimetry; Device
Lead sponsor: University of Auckland, New Zealand; Other
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Shared Decision-Making, Quality of Life, Advanced Illness, Terminal Illness
Interventions: Research Assistant Support; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 138 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Pain, Dementia
Interventions: Pain-CPG-EIT, Pain-CPG-Education Only; Behavioral · Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 60 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 11
States / cities: Baltimore, Maryland • Bel Air, Maryland • Columbia, Maryland + 5 more

Conditions: Status Epilepticus, Coma
Interventions: Rapid Response EEG; Device
Lead sponsor: Children's Hospital at Montefiore; Other
Eligibility: 2 Years to 18 Years
Enrollment: 60 participants
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Voice Disorders, Vocal Fold Polyp, Vocal Nodules in Adults, Muscle Tension Dysphonia
Interventions: Ambulatory Voice Monitoring with Biofeedback (AVM-B), Conversation Training Therapy; Device · Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Breast Carcinoma, Hormone Receptor-Positive Breast Carcinoma
Interventions: Non-Interventional Study; Other
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Vitiligo, Healthy
Interventions: Not listed
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Radiculopathy, Lumbosacral Region, Back Pain With Radiation, Low Back Pain
Interventions: Ibuprofen 400 mg, Dexamethasone Oral, Educational Intervention; Drug · Behavioral
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 132 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: The Bronx, New York

Conditions: Distal Aortic Dissection, Dissection, Aortic Acute, Acute Type B Aortic Dissection (Uncomplicated)
Interventions: BMT+TEVAR, BMT; Device · Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 436 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Crohn's Disease
Interventions: SL-325, Placebo; Drug
Lead sponsor: Shattuck Labs, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 232 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 20
States / cities: Little Rock, Arkansas • Oxnard, California • Temple City, California + 17 more

Conditions: Advanced Solid Tumors
Interventions: ATX-898, ATX-898, fulvestrant, ribociclib; Drug
Lead sponsor: Antares Therapeutics, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 343 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 5
States / cities: Fort Worth, Texas • Houston, Texas • San Antonio, Texas + 2 more

Conditions: Obstructive Sleep Apnea
Interventions: Acetazolamide 500 MG QHS, Eszopiclone 3 mg QHS; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 21 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 2
States / cities: Santa Monica, California • Westwood, Los Angeles, California

Conditions: Cerebral Palsy (CP), Motor Disability, Motor Delay
Interventions: Stander Use; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 1 Year to 6 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Type 2 Diabetes, Hyperglycemia
Interventions: Educational Intervention; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: New Brunswick, New Jersey

Conditions: HIV, Menopause, Cardiovascular (CV) Risk, Carotid Arteriosclerosis, Body Composition
Interventions: Whole body MRI; Diagnostic Test
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Female only
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: San Francisco, California

Conditions: End Stage Liver Disease
Interventions: LYG-LIV0001; Biological
Lead sponsor: LyGenesis, Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 2
States / cities: Boston, Massachusetts • Houston, Texas

Conditions: B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Marginal Zone Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Burkitt Lymphoma, Primary Mediastinal Large B-cell Lymphoma (PMBCL), Non Hodgkin Lymphoma, Mixed Phenotype Acute Leukemia
Interventions: Dose Level 1, VNX-101, Dose Level 2, VNX-101, Dose Level 3, VNX-101, Dose Level 4, VNX-101; Genetic
Lead sponsor: Vironexis Biotherapeutics Inc.; Industry
Eligibility: 13 Years to 90 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 11
States / cities: Duarte, California • Los Angeles, California • Denver, Colorado + 8 more

Conditions: Locally Advanced Skin Squamous Cell Carcinoma, Resectable Skin Squamous Cell Carcinoma, Unresectable Skin Squamous Cell Carcinoma
Interventions: Atezolizumab, Stereotactic Body Radiation Therapy; Biological · Radiation
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Duarte, California

Conditions: Hemostasis, Blood Biomarkers, Ultrasound
Interventions: Ultrasound Pulsed Doppler Imaging System; Device
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 50 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Drug Induced Liver Injury
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 2 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2028
U.S. locations: 6
States / cities: Los Angeles, California • Indianapolis, Indiana • Bethesda, Maryland + 3 more

Conditions: Advanced Melanoma
Interventions: Echopulse or Echopulse HD, PolyICLC; Device · Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Substance Use, Healthy
Interventions: fMRI, Questionnaires and surveys, Behavioral tasks and eye tracking; Device · Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 22 Years
Enrollment: 294 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Ann Arbor, Michigan

Conditions: Necrotizing Soft Tissue Infections
Interventions: Negative Pressure Wound Therapy, Negative Pressure Wound Therapy with Instillation; Device
Lead sponsor: HealthPartners Institute; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Search by objective public record fields.

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients: Baseline and Treatment Effects

Empowering Monterey Bay Residents for Activated, Collaborative, and Equitable Care

Testing the Pain Clinical Practice Guideline

Rapid-Response EEG in Children With Suspected Status Epilepticus

Project 4: Ambulatory Biofeedback and Voice Therapy for Patients With Vocal Hyperfunction

The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients

The Gut and Skin Microbiome in Vitiligo Disease Progression

Ibuprofen With or Without Dexamethasone for Acute Radicular Low Back Pain.

ACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy

A Study of SL-325 in Crohn's Disease Patients

A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors

Endotypic Traits and Obstructive Sleep Apnea Surgery

Complex Rehabilitation Technology Enabled Physical Activity for Children With Motor Delays Via Telehealth in Natural Environments

Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients

The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in Women

Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC

Ultrasound of the Spleen Utilizing Low-energy (Diagnostic Level) Insonification.

Drug-Induced Liver Injury (DILI) Network Retrospective

FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Neurobehavioral Signatures of Sign- and Goal-Tracking in Emerging Adults: Translation of a Preclinical Model

Irrigating vs Traditional Negative Pressure Wound Therapy to Treat Necrotizing Soft Tissue Infections